DE60027863D1 - Apherese von leukozyten aus blut zur behandlung von hiv - Google Patents

Apherese von leukozyten aus blut zur behandlung von hiv

Info

Publication number
DE60027863D1
DE60027863D1 DE60027863T DE60027863T DE60027863D1 DE 60027863 D1 DE60027863 D1 DE 60027863D1 DE 60027863 T DE60027863 T DE 60027863T DE 60027863 T DE60027863 T DE 60027863T DE 60027863 D1 DE60027863 D1 DE 60027863D1
Authority
DE
Germany
Prior art keywords
hiv
leucocytes
blood
treatment
apherese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60027863T
Other languages
English (en)
Other versions
DE60027863T2 (de
Inventor
Masakazu Adachi
Toshifumi Hibi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIMRO Co Ltd
Original Assignee
JIMRO Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP11072144A external-priority patent/JP2000262612A/ja
Application filed by JIMRO Co Ltd filed Critical JIMRO Co Ltd
Publication of DE60027863D1 publication Critical patent/DE60027863D1/de
Application granted granted Critical
Publication of DE60027863T2 publication Critical patent/DE60027863T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0439—White blood cells; Leucocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A61M2202/206—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Anesthesiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60027863T 1999-03-17 2000-02-25 Apherese von leukozyten aus blut zur behandlung von hiv Expired - Lifetime DE60027863T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP7214499 1999-03-17
JP11072144A JP2000262612A (ja) 1999-03-17 1999-03-17 Ｈｉｖ感染疾患の処置方法
GB9919565 1999-08-18
GBGB9919565.3A GB9919565D0 (en) 1999-03-17 1999-08-18 Treatment of disease
PCT/JP2000/001099 WO2000055621A2 (en) 1999-03-17 2000-02-25 Blood leucocyte apheresis for treatment of disease

Publications (2)

Publication Number Publication Date
DE60027863D1 true DE60027863D1 (de) 2006-06-14
DE60027863T2 DE60027863T2 (de) 2006-12-07

Family

ID=26315857

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60027863T Expired - Lifetime DE60027863T2 (de) 1999-03-17 2000-02-25 Apherese von leukozyten aus blut zur behandlung von hiv

Country Status (10)

Country Link
US (1) US6498007B1 (de)
EP (1) EP1126859B1 (de)
JP (1) JP4643830B2 (de)
AT (1) ATE325613T1 (de)
AU (1) AU2692900A (de)
DE (1) DE60027863T2 (de)
DK (1) DK1126859T3 (de)
ES (1) ES2262506T3 (de)
PT (1) PT1126859E (de)
WO (1) WO2000055621A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329388B2 (en) * 1997-07-30 2012-12-11 Cytosorbents, Inc. Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood
US20020198487A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids
US20020159995A1 (en) * 1997-07-30 2002-10-31 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
US20020197249A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products
US20020197250A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
US20020197252A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Selective adsorption devices and systems
US6878127B2 (en) 2001-04-10 2005-04-12 Renaltech International, Llc Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
DE10147638B4 (de) * 2001-09-27 2004-05-27 Leukocare Gmbh Leukozyten-Inaktivierungs-Modul (LIM)
JP2003235959A (ja) * 2002-02-14 2003-08-26 Nippon Koutai Kenkyusho:Kk Ｃ型肝炎ウイルスの除去・減量方法
JP4925829B2 (ja) * 2004-08-30 2012-05-09 株式会社カネカ 顆粒球吸着材
WO2006028202A1 (ja) * 2004-09-10 2006-03-16 Kaneka Corporation リンパ球増殖抑制因子の吸着材及び処理方法
JPWO2006106763A1 (ja) * 2005-03-30 2008-09-11 株式会社カネカ リンパ球増殖抑制因子の除去方法
KR100647335B1 (ko) 2005-04-15 2006-11-23 삼성전자주식회사 소수성 고체 지지체를 이용한 세포 분리 방법
EP1712284B1 (de) * 2005-04-15 2012-10-10 Samsung Electronics Co., Ltd. Methode zur Zelltrennung mit Benutzung hydrophober fester Träger
CN101267850B (zh) * 2005-09-09 2011-05-11 门布拉内有限公司 从血液中去除白细胞的方法
EP2035061A4 (de) * 2006-06-16 2012-02-01 Glycorex Transplantation Ab Adsorptionsvorrichtung
KR100813264B1 (ko) 2006-08-21 2008-03-13 삼성전자주식회사 비평면 형상의 고체 지지체를 이용하여 미생물로부터핵산을 증폭하는 방법
KR100813265B1 (ko) 2006-08-21 2008-03-13 삼성전자주식회사 비평면 형상의 고체 지지체를 이용하여 미생물로부터핵산을 증폭하는 방법
US8158411B2 (en) 2006-08-21 2012-04-17 Samsung Electronics Co., Ltd. Method of separating microorganism using nonplanar solid substrate and device for separating microorganism using the same
US20080044884A1 (en) * 2006-08-21 2008-02-21 Samsung Electronics Co., Ltd. Method and device for separating cells from a sample using a nonplanar solid substrate
KR100917465B1 (ko) * 2006-08-21 2009-09-14 삼성전자주식회사 비평면 형상의 고체 지지체를 이용하여 미생물을 분리하는방법 및 미생물분리 장치
EP2067495A4 (de) * 2006-09-29 2012-03-21 Toray Industries Zellen adsorbierende säule
JP5424894B2 (ja) * 2007-01-13 2014-02-26 メムブラーナ ゲゼルシャフト ミット ベシュレンクテル ハフツング 血液から白血球を除去するための装置
CA2789592C (en) * 2007-08-31 2015-05-12 The Regents Of The University Of Michigan Selective cytopheresis devices and related methods thereof
US20090149802A1 (en) * 2007-12-07 2009-06-11 Ross Peter Jones Surgical System Including a Trap for Noise-Inducing Materials
ES2628513T3 (es) * 2009-10-08 2017-08-03 Otsuka Pharmaceutical Co., Ltd. Un filtro de perfusión sanguínea de inmunoactivación para el tratamiento de tumores malignos
CA2814586C (en) 2010-10-15 2024-01-30 Cytopherx, Inc. Cytopheretic cartridge and use thereof
DE102010049790A1 (de) 2010-10-29 2012-05-03 Fresenius Medical Care Deutschland Gmbh Medizinische Trennvorrichtung
US20130068691A1 (en) * 2011-08-05 2013-03-21 Henry John Smith Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders
WO2013106108A2 (en) 2011-10-14 2013-07-18 Cytopherx, Inc. Cartridge and method for increasing myocardial function
EP2606921A1 (de) 2011-12-21 2013-06-26 Infomed SA Vorrichtung zur Blutreinigung durch extrakorporale Zirkulation
CN105246524B (zh) 2013-05-31 2017-05-31 东丽株式会社 吸附载体填充柱
US20170266362A1 (en) 2014-08-26 2017-09-21 3M Innovative Properties Company System for removal of pro-inflammatory mediators as well as granulocytes and monocytes from blood
US11383015B2 (en) * 2016-01-11 2022-07-12 Fenwal, Inc. System and method for plasma purification prior to mononuclear cell collection
CN106267414B (zh) * 2016-07-01 2019-02-19 翁炳焕 艾滋病免疫净化器
CN106267410B (zh) * 2016-07-01 2019-03-08 翁炳焕 艾滋病感染细胞分离器
CN106166313B (zh) * 2016-07-01 2018-09-07 浙江大学 一种艾滋病孕妇血液净化器

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906742A (en) * 1986-07-31 1990-03-06 Whitehead Institute For Biomedical Research Encoding antigens of M. Leprae
JP2673567B2 (ja) 1987-12-10 1997-11-05 株式会社日本抗体研究所 血液中の顆粒球除去方法及びこれに用いる顆粒球除去装置
US5807881A (en) 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
US5567443A (en) * 1993-08-04 1996-10-22 Japan Immunoresearch Laboratories Co., Ltd. Method of treating inflammatory diseases
US5525279A (en) 1994-04-04 1996-06-11 Sekisui Kagaku Kogyo K.K. Method of forming a granulocyte adsorbing carrier and granulocyte remover

Also Published As

Publication number Publication date
DK1126859T3 (da) 2006-08-28
JP2002539178A (ja) 2002-11-19
ES2262506T3 (es) 2006-12-01
AU2692900A (en) 2000-10-04
EP1126859B1 (de) 2006-05-10
WO2000055621A2 (en) 2000-09-21
PT1126859E (pt) 2006-09-29
WO2000055621A8 (en) 2001-07-05
EP1126859A2 (de) 2001-08-29
DE60027863T2 (de) 2006-12-07
ATE325613T1 (de) 2006-06-15
JP4643830B2 (ja) 2011-03-02
WO2000055621A3 (en) 2001-04-19
US6498007B1 (en) 2002-12-24

Similar Documents

Publication Publication Date Title
DE60027863D1 (de) Apherese von leukozyten aus blut zur behandlung von hiv
NO920834D0 (no) Fremgangsmaate for inaktivering av virus i blod og blodprodukter
AU580402B2 (en) Method of inactivating viruses involving adsorption on solid phase
EA200100050A1 (ru) Метод удаления бета-2 микроглобулина из крови
DE69638094D1 (de) Verfahren und vorrichtungen zur entfernung von psoralenen aus blutprodukten.
DE69929986D1 (de) Verfahren zur entfernung von hiv und anderen viren aus blut
DE3674941D1 (de) Ozonentkeimung von blut und blutprodukten.
ATE194921T1 (de) Verfahren zur inaktivierung von viren
ATE138575T1 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
ATE195891T1 (de) Sorbentmittel und dessen herstellungsverfahren
ATE105188T1 (de) Reinigung von pertussis-toxinen und herstellung von vakzine.
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
DE59002994D1 (de) Vorrichtung zur selektiven Elimination von Plasmabestandteilen aus Blut.
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
DK577181A (da) Polypeptidfraktioner fra muslinger
DE59209133D1 (de) Verfahren zur Herstellung eines virussicheren Thrombinkonzentrates
ATE205112T1 (de) Alkalibeständiges proteinadsorbens
ATE233275T1 (de) Verfahren zur entfernung von erregern übertragbarer spongiformer encephalophatien aus proteinlösungen
EA200400751A1 (ru) Применение дезоксипеганина для лечения клинической депрессии
ATE526977T1 (de) Verfahren zur inaktivierung infektioeser erreger in biologischen flüssigkeiten
ATE180672T1 (de) Verfahren zur herstellung von infektionsfreien pharmazeutischen präparaten und/oder nahrungsmitteln aus infektiösem, insbesondere prionen enthaltendem, material
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
DE69825745D1 (de) Verfahren zur entfernung von schwermetallen
TH66153A (th) การรักษาโรค
DK1094846T3 (da) Fjernelse af desinficerende farvestof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition